Vankova Hausnerova V, Shoman M, Kumar D, Schwarz M, Modrak M, Jirat Matejckova J
Nucleic Acids Res. 2024; 52(8):4604-4626.
PMID: 38348908
PMC: 11077062.
DOI: 10.1093/nar/gkae081.
Abilev S, Igonina E, Sviridova D, Smirnova S
Biosensors (Basel). 2023; 13(5).
PMID: 37232872
PMC: 10216269.
DOI: 10.3390/bios13050511.
Dormousoglou M, Efthimiou I, Antonopoulou M, Dailianis S, Herbst G, Vlastos D
Plants (Basel). 2023; 12(7).
PMID: 37050163
PMC: 10097089.
DOI: 10.3390/plants12071537.
Efthimiou I, Vlastos D, Triantafyllidis V, Eleftherianos A, Antonopoulou M
Plants (Basel). 2022; 11(20).
PMID: 36297697
PMC: 9611029.
DOI: 10.3390/plants11202673.
Miaskiewicz S, Weibel J, Pale P, Blanc A
RSC Adv. 2022; 12(41):26966-26974.
PMID: 36275169
PMC: 9490519.
DOI: 10.1039/d2ra05685b.
Novel NRF2-activated cancer treatments utilizing synthetic lethality.
Baird L, Kensler T, Yamamoto M
IUBMB Life. 2022; 74(12):1209-1231.
PMID: 36200139
PMC: 10092255.
DOI: 10.1002/iub.2680.
Safety and efficacy of combination of suberoylamilide hydroxyamic acid and mitomycin C in reducing pro-fibrotic changes in human corneal epithelial cells.
Shetty R, Kumar N, Subramani M, Krishna L, Murugeswari P, Matalia H
Sci Rep. 2021; 11(1):4392.
PMID: 33623133
PMC: 7902619.
DOI: 10.1038/s41598-021-83881-y.
NRF2-Dependent Bioactivation of Mitomycin C as a Novel Strategy To Target KEAP1-NRF2 Pathway Activation in Human Cancer.
Baird L, Yamamoto M
Mol Cell Biol. 2020; 41(2).
PMID: 33139492
PMC: 8093492.
DOI: 10.1128/MCB.00473-20.
Safety and Efficacy of s-MOX Regimen in Patients with Colorectal Cancer Who Developed Cardiotoxicity Following Fluoropyrimidine Administration: A Case Series.
Ehrlich M, Kaley K, Smith M, Saif M
Arch Med Case Rep. 2020; 2(1):23-29.
PMID: 32964213
PMC: 7504879.
Mechanisms of direct replication restart at stressed replisomes.
Conti B, Smogorzewska A
DNA Repair (Amst). 2020; 95:102947.
PMID: 32853827
PMC: 7669714.
DOI: 10.1016/j.dnarep.2020.102947.
Hypoxia-active nanoparticles used in tumor theranostic.
Wang Y, Shang W, Niu M, Tian J, Xu K
Int J Nanomedicine. 2019; 14:3705-3722.
PMID: 31190820
PMC: 6535445.
DOI: 10.2147/IJN.S196959.
Hypoxia-targeted drug delivery.
Sharma A, Arambula J, Koo S, Kumar R, Singh H, Sessler J
Chem Soc Rev. 2018; 48(3):771-813.
PMID: 30575832
PMC: 6361706.
DOI: 10.1039/c8cs00304a.
Interdependent Sequence Selectivity and Diastereoselectivity in the Alkylation of DNA by Decarbamoylmitomycin C.
Aguilar W, Paz M, Vargas A, Zheng M, Cheng S, Champeil E
Chemistry. 2018; 24(50):13278-13289.
PMID: 29958326
PMC: 7152928.
DOI: 10.1002/chem.201802038.
Crosstalk Between Apoptosis and Autophagy Is Regulated by the Arginylated BiP/Beclin-1/p62 Complex.
Song X, Lee D, Dilly A, Lee Y, Choudry H, Kwon Y
Mol Cancer Res. 2018; 16(7):1077-1091.
PMID: 29669822
PMC: 6030503.
DOI: 10.1158/1541-7786.MCR-17-0685.
Sequence-Dependent Diastereospecific and Diastereodivergent Crosslinking of DNA by Decarbamoylmitomycin C.
Aguilar W, Paz M, Vargas A, Clement C, Cheng S, Champeil E
Chemistry. 2018; 24(23):6030-6035.
PMID: 29504661
PMC: 7046179.
DOI: 10.1002/chem.201705771.
Ginsenosides synergize with mitomycin C in combating human non-small cell lung cancer by repressing Rad51-mediated DNA repair.
Zhao M, Wang D, Che Y, Wu M, Li Q, Shao C
Acta Pharmacol Sin. 2017; 39(3):449-458.
PMID: 28836581
PMC: 5843838.
DOI: 10.1038/aps.2017.53.
DNA damage tolerance pathway involving DNA polymerase ι and the tumor suppressor p53 regulates DNA replication fork progression.
Hampp S, Kiessling T, Buechle K, Mansilla S, Thomale J, Rall M
Proc Natl Acad Sci U S A. 2016; 113(30):E4311-9.
PMID: 27407148
PMC: 4968756.
DOI: 10.1073/pnas.1605828113.
Comparative Error-Free and Error-Prone Translesion Synthesis of N(2)-2'-Deoxyguanosine Adducts Formed by Mitomycin C and Its Metabolite, 2,7-Diaminomitosene, in Human Cells.
Bose A, Surugihalli C, Pande P, Champeil E, Basu A
Chem Res Toxicol. 2016; 29(5):933-9.
PMID: 27082015
PMC: 4871107.
DOI: 10.1021/acs.chemrestox.6b00087.
Improving cancer therapies by targeting the physical and chemical hallmarks of the tumor microenvironment.
Ivey J, Bonakdar M, Kanitkar A, Davalos R, Verbridge S
Cancer Lett. 2016; 380(1):330-9.
PMID: 26724680
PMC: 4919249.
DOI: 10.1016/j.canlet.2015.12.019.
Genome-Wide Mutational Signature of the Chemotherapeutic Agent Mitomycin C in Caenorhabditis elegans.
Tam A, Chu J, Rose A
G3 (Bethesda). 2015; 6(1):133-40.
PMID: 26564951
PMC: 4704711.
DOI: 10.1534/g3.115.021915.